Vice President Marketing
Europe, India and APAC
Vice President Corporate Communications
Steven N. Barlow
Vice President Investor Relations
How Life Sciences Companies Can Make a Difference During the COVID-19 Pandemic - Managed Healthcare Executive
Life sciences companies can use geographic analysis as the basis of forming partnerships with providers to improve health outcomes in areas likely to be hard-hit by the COVID-19 pandemic.
By Susan Willman
Preventing the Aftershocks from COVID-19 - Healthcare Business Today
While there is little that can be done to stop the aftershocks of an actual earthquake, the same is not true for those generated by COVID-19. At the most basic level, one of the most important steps both health plans and providers can take is to use predictive analytics to monitor utilization of services for chronic conditions so they can uncover care gaps and remediate them before conditions become catastrophic.
By Dr. Victor Collymore
How Life Sciences Companies Can Promote Greater Medication Adherence During COVID19 - PharmaExec
As the global COVID-19 pandemic has continued to develop, it has become apparent that people at the highest risk for complications are those who were already experiencing chronic conditions such as diabetes, chronic obstructive pulmonary disease (COPD), asthma and heart disease.
By John Pagliuca & Prasad Dindigal
EXL Achieves Leader and Star Performer Designations in Everest Group PEAK Matrix® Assessment 2020 for Property and Casualty Insurance BPO
NEW YORK, April 29, 2020 - EXL [NASDAQ: EXLS], a leading Operations Management and Analytics company, today announced it has achieved placement as a Leader and Star Performer in the “Everest Group PEAK Matrix® for P&C Insurance BPO 2020.” The report, which positioned EXL in the top-most spot for Market Impact, highlighted EXL’s double-digit revenue growth, investments in digital solutions, and capabilities across the insurance value chain.
Getting Ahead of Emerging COVID-19 Hot Spots - For The Record
From the beginning of the COVID-19 pandemic, it has felt like the health care industry has been playing catch-up. Given the fact that the virus and its impact were unknown, clinical leaders and others had to learn about its nature and underlying factors on the fly as they were attempting to treat this devastating pandemic.
By Dr. Victor Collymore & Dave Hom